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Abstract
Exercise provides clear beneficial effects for the prevention of numerous diseases. However, many of the molecular events
responsible for the curative and protective role of exercise remain elusive. The recent discovery of FNDC5/irisin protein that
is liberated by muscle tissue in response to exercise might be an important finding with regard to this unsolved mechanism.
The most striking aspect of this myokine is its alleged capacity to drive brown-fat development of white fat and
thermogenesis. However, the nature and secretion form of this new protein is controversial. The present study reveals that
rat skeletal muscle secretes a 25 kDa form of FNDC5, while the 12 kDa/irisin theoretical peptide was not detected. More
importantly, this study is the first to reveal that white adipose tissue (WAT) also secretes FNDC5; hence, it may also behave
as an adipokine. Our data using rat adipose tissue explants secretomes proves that visceral adipose tissue (VAT), and
especially subcutaneous adipose tissue (SAT), express and secrete FNDC5. We also show that short-term periods of
endurance exercise training induced FNDC5 secretion by SAT and VAT. Moreover, we observed that WAT significantly
reduced FNDC5 secretion in fasting animals. Interestingly, WAT of obese animals over-secreted this hormone, which might
suggest a type of resistance. Because 72% of circulating FNDC5/irisin was previously attributed to muscle secretion, our
findings suggest a muscle-adipose tissue crosstalk through a regulatory feedback mechanism.
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Introduction
Last January 2012 Boström and colleagues identified a new
muscle-tissue-secreted peptide termed Irisin [1]. Interestingly, this
myokine, whose secretion depends on the PGC1a transcriptional
co-activator, seems to be capable to induce white adipose tissue
(WAT) browning. Because the function of brown adipose tissue
(BAT) is specialized to dissipate chemical energy as heat, the
relevance of this finding if further confirmed, would be promising.
Recent reports using 18 fluoro-labeled 2-deoxy-glucose positron
emission tomography (18FDG-PET) have shown that, contrary to
previously thought, normal adult humans have distinct brown fat
deposits. Moreover, the thermogenic activity of this tissue is
inversely correlated with overall adiposity, which suggests that
variations in the amount or activity of BAT are related to the
susceptibility for weight gain in humans [2–6]. Thus, BAT has
recently acquired increasing relevance due to its potential role in
the defense against obesity and obesity-associated disorders [7].
However, a current controversy has arisen concerning FNDC5/
irisin and its expression in humans who exercise as well as its true
relationship with metabolic status [8].
The transcriptional co-activator PGC1a is involved in many
biological programs related to energy metabolism. PGC1a was
initially implicated in the expression of UCP-1 and thermogenesis
in brown fat through PPAR-c [9] as well as the control of
mitochondrial biogenesis and oxidative metabolism in many cell
types. More recently, it was shown that PGC1a is induced in
muscle by exercise stimulating several of the beneficial effects of
exercise in this tissue [10]. Consequently, mice with transgenically
increased PGC1a in their muscles are resistant to age-related
obesity and diabetes [11]. Built on these premises, Boström’s work
reveals that exercise and PGC1a stimulates the expression of the
FNDC5 gene in muscle. This gene encodes a Type I membrane
protein that might be proteolytically processed to form the
secreted myokine irisin. However, these authors were unable to
detect the 12 kDa soluble form of irisin in their experiments.
Relevantly, they showed that treating primary subcutaneous white
adipocytes during differentiation with Fndc5 induced the activa-
tion of browning and thermogenic genes such as UCP1 in vitro.
Furthermore, they showed that FNDC5/irisin was significantly
elevated in plasma after endurance exercise in mice and humans
and that circulating increments of this myokine forced with
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adenoviral vectors that expressed the full length of FNDC5
increased energy expenditure in mice with no changes in
movement or food intake [1].
Given the relevance of the FNDC5/irisin discovery as well as its
controversy and potential functions, a need to obtain additional
information regarding the nature of this hormone and its precise
role in energy homeostasis, including its participation in food-
related disorders, exists. We believe that the present study sheds
light about FNDC5 secretion from skeletal muscle and more
relevantly, we set a new paradigm by demonstrating that FNDC5/
irisin is not just a myokine liberated by muscle tissue but also an
adipokine released by white and to a lesser extent, by brown
adipose tissue. Interestingly, we show that adipose-FNDC5/irisin
expression and secretion varies according to the type of fat depot
and that exercise and nutritional status influence its secretion.
Moreover, we describe its deregulation in food-related disorders.
Materials and Methods
Ethics Statement
The authors of this manuscript declare that the animal work in
this study was performed according to the protocols approved by
the Animal Care Committee of Santiago de Compostela
University (Santiago de Compostela, Spain). Furthermore, the
human adipose tissue specimen was obtained with written
informed consent approved for this particular study by the Comité
Ético de Investigación Clı́nica de Galicia – CEIC de Galicia
(Spain) according to the Declaration of Helsinki.
Animal Models
Male Sprague Dawley rats (160 g) were housed in 12-h light/
12-h dark cycles with free access to a standard chow diet and
water. After 5 days of acclimatization, weight-matched animals
were assigned to one the following experimental groups (n = 5 per
group): a) control ad libitum, b) 36 hours fasting, c) re-feed
(36 hours fasting followed by 15 minutes of feeding), d) exercise
(ad libitum with free access to the activity wheel for 1 or 3 weeks),
e) control activity-based anorexia (ABA) and f) ABA as previously
described and listed in Table S1 [12,13]. The body weight, food
intake, daily wheel turns, body composition and hormonal
determination (ghrelin, leptin and HOMA) of these animals were
previously characterized [13]. Diet-induced obesity (DIO) animals
(200 g) were fed with a 60% high fat diet D12492 (Research Diets,
NJ) over 9 weeks, and age-matched lean rats were used as a
control. Male obese Zucker rats (fa/fa, n = 10) and their control
counterparts, lean Zucker rats (fa/-, n = 10), were purchased from
Charles River laboratories (Barcelona, Spain) at 10 weeks of age
and were fed chow ad libitum for 12 weeks. Animals were
euthanized by decapitation; their blood was collected, and their
tissues were surgically excised.
Rat muscle/adipose tissues and secretomes processing
The soleus and gastrocnemius muscles, the subcutaneous
adipose tissue from the skin of the hips, the visceral fat located
inside the peritoneal cavity around the internal organs and the
brown (interscapular area) fat locations were processed for
secretome collection based on a previously optimized protocol to
minimize tissue damage [14,15]. Briefly, tissues (n = 5 from each
muscle type/fat depot) were carefully excised minimizing rat hair
contamination as much as possible and transported from the
animal house operating room to the laboratory in a sterile Krebs –
Ringer-Hepes (KRH) buffer with penicillin (100 U/ml) and
streptomycin (100 mg/ml) at room temperature. The tissues were
processed to eliminate any contaminants and washed thoroughly
in KRH under sterile conditions in a flow laminar hood. Adipose
tissue pieces were centrifuged in a 25 ml tube with 20 ml of KRH
for 5 minutes at room temperature to remove blood cells and cell
debris. Fat pieces of approximately 2 g were incubated in 6 well
cell culture dishes (Iwaki, Tokio, Japan) in 4 ml of serum-free
medium that was changed twice every two hours and again after
16 hours. Finally, fresh 4 ml of serum/phenol red free DMEM
medium was added and incubated for 24 hours. Whole muscle
tissues were incubated in 6 well cell culture dishes (Iwaki, Tokyo,
Japan) with 5 ml of serum-free medium that was changed twice
every two hours and again after 16 hours. Finally, 3 ml of fresh
serum/phenol red free DMEM medium was added and incubated
for 12 hours. Secretomes were immediately processed for sample
concentration (corrected per gram of tissue) by ultra centrifugation
units (Amicon Ultra 3-kDa cut off, Millipore, Billerica, USA). A
fragment of each adipose depot type and muscles from opposite
legs were frozen at 280uC for western blot and quantitative real-
time PCR (QRT-PCR) studies.
Immunoblotting
Protein extracts from whole tissue samples and secretomes were
processed as previously described [13,14]. Briefly, proteins of
whole tissue samples were extracted by homogenization using a
TissueLyser II (QIAGEN, Tokio, Japan) in cold RIPA buffer
[200 mM Tris/HCl (pH 7.4), 130 mM NaCl, 10% (v/v) glycerol,
0.1% (v/v) SDS, 1% (v/v) Triton X-100, 10 mM MgCl2] with
anti-proteases and anti-phosphatases (Sigma-Aldrich; St Louis,
MO). Homogenates were centrifuged for 30 minutes at 18,000 g
in a microfuge at 4uC, and supernatants were frozen at 280uC.
Twenty-five mg of adipose tissue secreted proteins, 25 mg of whole
tissue and 5 ml of blood plasma from three independent
experiments were separated in 12% SDS-PAGE gels and
electroblotted onto nitrocellulose membranes as previously
described [13]. Equal loading was confirmed by membrane
staining with Ponceau S (Sigma-Aldrich; St Louis, MO) in the case
of secretome protein extracts, or by measuring the amount of
GAPDH in whole tissue protein extracts. Primary anti-FNDC5,
anti-UCP-1 and anti-PGC1 were purchased from Abcam (Cam-
bridge, UK); anti-Irisin was purchased from Phoenix Pharmaceu-
ticals Inc. (CA, USA); anti-IL6 and anti-Adiponectin were
purchased from Santa Cruz Biotechnology Inc. (CA, USA); anti-
GAPDH was purchased from Life Technologies Ltd (Paisley, UK).
Data were expressed as percentages corrected towards GADPH
(arbitrary units) in Western blots with mean 6 SEM. Data
analyses were conducted using GraphPad Prism 5 software with a
Mann-Whitney U test in which * p,0.05 and ** p,0.01 were
considered significant and very significant, respectively.
Human adipose tissue acquisition
Human adipose tissue was obtained from an obese patient (body
mass index .35) who underwent laparoscopic gastrectomy
surgery. The visceral fat was located in the hypogastric region
around the internal organs, and the subcutaneous fat was located
in the mesogastric region. The tissues were transported from the
operating room to the laboratory in sterile KRH buffer with
penicillin (100 U/ml) and streptomycin (100 mg/ml) and pro-
cessed as described above for the rat adipose tissue.
Isolation of mature adipocytes and stromo-vascular
fraction (SVF)
Five g of rat adipose tissue from the visceral and subcutaneous
locations was washed three to four times with KRH buffer, cut in
pieces less than 1 mg and resuspended in an equal volume of 0.2%
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pre-warmed (37uC) collagenase Type I (Gibco, CA). This tissue
was placed in an orbital mixer at 37uC with continuous agitation
for 90 minutes. Then, it was centrifuged for 5 minutes at 400 g at
room temperature. The supernatant that contained mature
adipocytes was recollected. The pellet was identified as the SVF.
Cell culture
The cell line 3T3-L1 was grown in DMEM with 10% fetal
bovine serum (FBS), 100 U/ml of penicillin and 100 mg/ml of
streptomycin until differentiation to adipocytes as previously
described [16].
RNA isolation and quantitative real-time PCR
Total RNA was isolated from adipose tissue from five
independent experiments (i.e., different animals) using Trizol
(Invitrogen, CA, USA) according to the manufacturers recom-
mendations. Quantitative real-time PCR was performed using a
Real Time PCR Systems Step One Plus (Applied Biosystems) with
specific Taqman qRT-PCR primers as described elsewhere [17].
The levels of FNDC5 and PGC1 were normalized for the gene-
expression analysis using hypoxanthine phosphoribosyltransferase
1 (HPRT1) rRNA (TaqMan: Applied Biosystems) as a house-
keeping gene and were expressed with respect to the average value
in the control group.
Results
White adipose tissue secretes FNDC5/irisin, which is
modulated by exercise and nutritional status
While characterizing FNDC5/irisin myokine regulation under
different nutritional and pathological situations, we discovered that
rat adipose tissue is able to express and secrete this novel peptide.
Whole tissue and secretome samples from rat skeletal muscle and
white adipose tissues were collected as indicated in the methods
section following protocols previously described by our group
[14,18] and assessed for FNDC5/irisin secretion and expression.
To confirm the viability and nature of the collected secretomes, we
first tested the secretion of IL-6 and adiponectin as reference
myokine and adipokine, respectively (Figures 1A, B). As expected,
both gastrocnemius and soleus tissues showed IL-6 secretion that
significantly increased with exercise [19] (Figure 1A); on the other
hand, we confirmed that subcutaneous adipose tissue secretes
more adiponectin than visceral fat [20] and that this secretion
significantly increased after one week of exercise [21] (Figure 1B).
Next, we examined PGC1a mRNA expression and observed that
no significant differences existed among samples in either muscle
or adipose tissues (Figure 1C, D). Nevertheless, one week of
exercise moderately increased PGC1a in subcutaneous and
visceral adipose tissues.
Once the secretomes were characterized, we analyzed FNDC5/
irisin secretion levels by immunodetection among the same
secretome samples (Figure 1E–F). Because the molecular weight
of the secreted form of FNDC5/irisin remains controversial and
not well characterized, we analyzed muscle and adipose tissue
secretomes using an anti-FNDC5 antibody directed against the
theoretically non-secreted portion of the protein (amino acids 149–
178 from Abcam) and an anti-Irisin antibody directed against the
predicted 12 kDa excised form (amino acids 42–112 from Phoenix
Pharmaceuticals). Figures 1E and F show the full immunoblot
picture where a predominant band of 25 kDa was detected in
muscle and adipose tissue secretomes with both antibodies.
Surprisingly, we were unable to detect a strong 12 kDa band
signal with the anti-irisin antibody (Figure 1F). However, the anti-
irisin antibody detected a strong band for the 25 kDa complete
protein with an expression pattern identical to the immunoblot
performed with the anti-FNDC5 antibody (indicated with arrows
in Figure 1E and F). In addition, both antibodies were able to
detect extra bands with higher and, to a lesser extent, lower
molecular weights. The densitometry of 5 independent experi-
ments expressed as percentages in reference to the soleus 25 kDa
FNDC5/irisin secretion levels is shown in Figure 1G. Interestingly,
we observed that, under basal conditions, slow-oxidative fiber-type
muscle (soleus) secretes approximately 40% more FNDC5/irisin
than fast-glycolytic fiber-type muscle (gastrocnemius), 20% more
than subcutaneous adipose tissue, and approximately 60% more
than visceral adipose tissue (Figure 1G). Confirming the observa-
tions in humans [1], both the soleus and gastrocnemius muscles
showed a significant increase of FNDC5/Irisin secretion after
three weeks of voluntary exercise. Excitingly, subcutaneous and
visceral adipose tissues showed increased secretion after only one
week of exercise (Figure 1G).
Given the interesting finding linking adipose tissue with
FNDC5/irisin, we decided to better characterize the expression
and secretion of this protein in adipose tissue under different
nutritional and pathological situations. When comparing adipose
tissues from different anatomical localizations, we observed that
SAT expressed and secreted 40% more FNDC5/irisin than VAT;
nevertheless, BAT barely expressed and secreted FNDC5/irisin
compared with SAT and VAT under the ad libitum condition
(Figures 2A and 3A). In addition, we confirmed that one week of
endurance exercise significantly increased FNDC5/irisin expres-
sion and secretion in SAT (46%) and VAT (36%); however, after
three weeks of training, FNDC5/irisin secretion significantly
diminished in both fat deposits compared with non-exercised
controls (Figure 2B). Moreover, we observed that 36 hours of
fasting significantly decreased FNDC5/irisin liberation and
expression in both SAT and VAT (Figure 2C and 3C); this effect
reverted in both tissues secretion after re-feeding fasting animals
for 15 minutes (Figure 2C). Conversely, fasting did not affect
FNDC5/irisin secretion in BAT (Figure 2C).
Adipose FNDC5/irisin secretion under pathological
situations
Because knowing whether adipose FNDC5/irisin plays a role in
pathological situations is of interest, we examined FNDC5/irisin
secretion and expression in obese animals. Rats with either diet-
induced obesity (DIO) or genetic obesity (Zucker rats) showed a
significant increase of FNDC5/irisin secretion in both SAT and
VAT tissues compared with their lean counterparts (Figure 2D
and E). Furthermore, we studied a well-characterized rat model
for anorexia, activity based anorexia (ABA), which also included
control animals with voluntary exercise (EXER) and food
restriction (CABA) [14]. FNDC5/irisin detection in the SAT
and VAT of anorexic animals did not reveal differences compared
with ad libitum control animals (Figure 2D and E). Control
animals that voluntarily exercised for one week showed a
significant increase of FNDC5/irisin secretion in their SAT and
VAT as described above (Figure 2D and E). Moreover, the VAT
from CABA animals under the same fasting regime as ABA
animals but without exercise, showed considerably less FNDC5/
irisin liberation; this effect was reverted by exercise in VAT from
ABA animals (Figure 2E). The FNDC5 protein expression and
mRNA levels were assessed for all experimental settings and are
shown in Figure 3.
Circulating FNDC5/irisin
FNDC5/Irisin circulating levels were assessed in plasma
samples from all the animals studied above (Figure 2F). This
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analysis revealed a significant increase in FNDC5/irisin levels after
1 and 3 weeks of exercise, after 36 hours of fasting and after
15 minutes of re-feeding. Corroborating this finding, we detected
a significant increase of FNDC5/irisin levels in ABA control
exercised animals (EXER) and CABA. However, DIO and Zucker
rats had opposite circulating levels of FNDC5/irisin; whereas DIO
animals showed a significant increase, Zucker rats showed
significantly diminished levels.
Adipose tissue ‘‘browning’’
Considering the described potent effect of FNDC5/irisin
stimulating white adipose browning and thermogenesis [1], we
tested Ucp1 expression on the subcutaneous and visceral adipose
tissues analyzed above (Figure 4). Under normal ad libitum
conditions, Ucp1 was expressed exclusively in BAT as expected
(Figure 4A). However, this expression shows a decreasing trend
after 3 weeks of endurance exercise (Figure 4A).
In the case of pathological animal models, detection of Ucp1
expression in SAT and VAT adipose tissues from either obese or
lean animals was not possible. The same lack of expression in SAT
was also observed among ABA rats and their control counterparts
(Figure 4B); however, a strikingly high expression was detected in
VAT among exercised (EXER), fasting (CABA) or both (ABA)
animals (Figure 4B).
PGC1a protein expression
Given the implication of PGC1a in energy metabolism, and its
role in activating FNDC5 in exercising muscle, we analyzed its
expression at protein level in all the experimental situations
established in our study (Figure 5). Generally, we did not find
differences in PGC1a protein expression in WAT or BAT at
different physiological or pathological situations (Figure 5A–E).
However, we observed a significant increase of PGC1a in SAT
after one week of exercise training; this elevation on PGC1a was
reverted after longer periods of exercise (Figure 5B). In addition,
Figure 1. Muscle and adipose tissue sample viability and FNDC5 secretion characterization. The presence of IL-6 and adiponectin in
muscle (oxidative-soleus and glycolytic-gastrocnemius) and adipose tissue (subcutaneous and visceral) secretomes assessed by western blot are
shown in corresponding histograms for band quantification (A and B). PGC1a expression was tested in the same samples by real-time PCR (C and D).
The presence of whole FNDC5 (E) and the soluble form of irisin (F) in muscle and adipose tissues are shown in representative images. Histograms of
the band quantification from at least 3 independent experiments are shown, and significance is indicated with regard to the control soleus (*p,0.05;
**p,0.01) or towards its own tissue control (#p,0.05) (G). CONT: control ad libitum animals; 1 and 3 W: 1 and 3 weeks of exercise training.
doi:10.1371/journal.pone.0060563.g001
Figure 2. Adipose tissue secretion of FNDC5/irisin. FNDC5/irisin secretion was assessed in adipose tissue secretomes from SAT, VAT and BAT
under ad libitum conditions (A); in SAT and VAT secretomes from animals after one and three weeks of exercise training (B); and in SAT, VAT and BAT
from animals with 36-h food restriction or re-feed after 15 minutes (C). FNDC5/irisin SAT and VAT secretion from the DIO and Zucker animal models
and anorexic animals are also shown (D, E). Irisin circulating levels for all previous situations are shown taking the most intense band at 25 kDa (F).
Representative images of western blots and histograms of band quantifications from at least 3 independent experiments are shown. The results are
represented as percentages with regard to each control as well as significance. In the situation of 3 weeks of exercise, results are compared with
1 week of exercise (*p,0.05; **p,0.01). SAT: subcutaneous adipose tissue; VAT: visceral adipose tissue; BAT: brown adipose tissue; DIO: diet induced
obesity; CDIO: control DIO; CZ (fa/-): control Zucker; Zucker: fa/fa; CONT: control; EXER: exercise; CABA: control ABA; ABA: activity based anorexia.
doi:10.1371/journal.pone.0060563.g002
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SAT from anorexic animals and VAT from DIO showed a
significant diminution of PGC1a (Figure 5D and 5E).
FNDC5/Irisin is secreted by rat mature adipocytes and
human adipose tissue
In an attempt to better characterize the nature of cells that
secrete irisin within adipose tissue, we assessed irisin secretion in
fractionated SAT and VAT rat primary cell cultures. The
immunoblots of the resulting secretomes confirmed that mature
adipocytes are responsible for adipose tissue irisin secretion in both
cases (Figure 6A). The differentiated 3T3-L1 cells also confirmed
this result (Figure 6B). Finally, we found that human SAT and
VAT also expressed and secreted FNDC5/irisin (Figure 6C).
Discussion
The recent discovery of the PGC1a-dependent myokine
FNDC5/irisin, which is able to stimulate brown-fat-like develop-
ment and thermogenesis in white fat both in vitro and in vivo, has
created a new field of research and many expectations in recent
months [1,22–27]. In this report, we are adding valuable novel
information concerning the role of FNDC5/irisin by investigating
the nature of its secretion, differences in muscle-tissue-type
secretion, and its potential function as an adipokine expressed
and secreted by WAT. Moreover, our results suggest that adipose-
tissue-secreted FNDC5/irisin is influenced by circulating levels of
this protein.
Although Boström and colleagues described the discovery of
FNDC5/irisin and its potential role, certain aspects regarding this
protein were not fully clarified in their manuscript or elsewhere
[1]. They consider that FNDC5 is synthesized as a Type I
membrane protein that is proteolytically cleavaged releasing the
amino terminal portion of the 12 kDa peptide, into the
extracellular space. To demonstrate the secretion of this myokine,
however, they used an Abcam antibody directed against the
endogenous portion of the protein (Abcam 149–178C-terminal).
Using this antibody, they detected substantial amounts of FNDC5
at a molecular weight of at least 32 kDa due to glycosylation in the
culture media of HEK 293 cells transfected with a vector that
expressed the C-terminal flag-tagged FNDC5. Using the same
antibody, however, they also detected a 22 kDa band in the
plasma of mice that had been forced to express FNDC5 by the
liver through the adenoviral intravenous delivery of a full-length
FNDC5 vector. Thus, these evidences suggest that the full length
Figure 3. Adipose tissue expression of FNDC5. FNDC5 expression was assessed in whole adipose tissue using QRT-PCR and western blot in the
same secretion study samples shown in Figure 2. Representative images of western blots and histograms of band quantification towards GAPDH
from at least 3 independent experiments are shown. Significant protein results are represented as percentages with regard to each control as well as
statistically significance (*p,0.05; **p,0.01). QRT-PCR results are shown as arbitrary units and compared with each control (*p,0.05). SAT:
subcutaneous adipose tissue; VAT: visceral adipose tissue; BAT: brown adipose tissue; DIO: diet induced obesity; CDIO: control DIO; CZ (fa/-): control
Zucker; Zucker: fa/fa; CONT: control; EXER: exercise; CABA: control ABA; ABA: activity based anorexia.
doi:10.1371/journal.pone.0060563.g003
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FNDC5/irisin is also secreted, as recently annotated in the
Uniprot protein Knowledgebase (UniProtKB Ref. Q8NAU1
Fibronectin Type III domain-containing Protein 5). Given this
context, we believe that the present paper contributes to clarify this
issue since we used the same antibody as Boström and colleagues
against the endogenous form of the protein (anti-FNDC5 Abcam
149–178C-terminal), and an additional antibody directed against
the theoretically soluble secreted form of 12 kDa (anti-Irisin
Figure 4. UCP1 detection in adipose tissue. Representative western blot images of UCP1 for SAT, VAT and VAT under ad libitum condition and
after 3 weeks of exercise are shown (A); UCP1 expression in SAT and VAT among anorexic and control counterparts is shown (B). Histograms of band
quantification from at least 3 independent experiments are shown in those cases in which bands exist. Significant protein results are shown as
percentages compared with controls in A and with regard to EXER in B (*p,0.05; **p,0.01).
doi:10.1371/journal.pone.0060563.g004
Figure 5. Adipose tissue expression of PGC1a. PGC1a expression was assessed in whole adipose tissue using western blot in the same secretion
study samples shown in Figure 2. Representative images of western blots and histograms of band quantification towards GAPDH from at least 3
independent experiments are shown. Significant protein results are represented as percentages with regard to each control (*p,0.05). SAT:
subcutaneous adipose tissue; VAT: visceral adipose tissue; BAT: brown adipose tissue; DIO: diet induced obesity; CDIO: control DIO; CZ (fa/-): control
Zucker; Zucker: fa/fa; CONT: control; EXER: exercise; CABA: control ABA; ABA: activity based anorexia.
doi:10.1371/journal.pone.0060563.g005
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Phoenix Pharmaceuticals amino acids 42–112) to characterize the
FNDC5/irisin myokine regulation in rats under different nutri-
tional and pathological conditions. Interestingly and in accordance
with Boström’s results, we detected a predominant band of
approximately 25 kDa in both cases as well as extra bands of
glycosylation, especially when using the anti-irisin antibody. This
antibody also showed a faint band at approximately 12 kDa that
could not be quantified. Thus, we analyzed the 25 kDa band in all
our experiments. In the case of serum western blots, we detected
extra bands of different intensities that might be the result of
protein de-glycosylation at circulating level. To our knowledge, the
direct secretion of the 12 kDa form of irisin from muscles or other
tissues has not been described so far.
Regarding the experimental design chosen to analyze the role of
FNDC5/irisin in the present work, it could be argued that
contaminant or non-expected proteins might be present in the
secretomes. The occurrence of unexpected proteins is related to
unavoidable cell breakage and artifacts or to the ability of proteins
to translocate between intra- and extracellular compartments in
unconventional ways [28–30]. We have previously shown that
these contaminants are constantly present in adipose tissue
secretomes without finding any variation within their physiological
or pathological state [14]. Thus we believe that the FNDC5/irisin
protein detected in our western blots corresponds to muscle or
adipose tissue active secretion because its levels are variable and
comparable with previously published studies [1].
In the current study, we were unable to detect a significant
increase of PGC1a expression in the exercised muscles of rats
(after 3 weeks of voluntary wheel running followed by 12 hours
rest before euthanasia), which parallels previous reports [8,31].
Conversely, we observed a positive correlation between exercise
and PGC1a expression levels in adipose tissue as previously
described [32], which correlated with FNDC5/irisin secretion
pattern. Nevertheless, this correlation was not found in those
experimental situations different from exercise in our study. Thus,
these results suggest an additional regulation of FNDC5 indepen-
dent of PGC1a in adipose tissue.
Knowing the importance of the role of adipose tissue on energy
homeostasis and its participation in obesity [33,34], the discovery
of FNDC5/irisin as a new adipokine described in our manuscript
suggests an autocrine and most likely an endocrine function for
this peptide in adipose tissue. Thus, given that approximately 72%
of circulating FNDC5/irisin comes from muscle tissue [1],
adipose-tissue-secreted FNDC5/irisin might participate in the
remaining 28%. According to our previous analysis on adipose
tissue secretion [14], FNDC5/irisin shows a distinct pattern of
secretion that depends on the anatomical location of fat. Thus, the
fact that SAT secretes much more FNDC5/irisin than other fat
deposits is expected after accounting for the ‘‘beneficial’’ role of
this type of tissue compared with visceral fat, which has been
shown to participate in the metabolic complications associated
with weight gain and obesity [35,36]. In relation to exercise, it is of
interest the early pattern of secretion observed in adipose tissue
compared to muscle [1]. Our results indicate that WAT increases
FNDC5/irisin secretion with short-term exercise (1 week), where-
as 3 weeks of exercise significantly decrease FNDC5/irisin
secretion. Many questions must be answered regarding the role
of adipose-FNDC5/irisin; however, if FNDC5/irisin it is able to
drive WAT into BAT as indicated by Boström [1], it seems that it
is not in the interest of WAT to stimulate thermogenesis and
energy consumption under prolonged exercise. Consequently, we
observed that 36 hours of fasting reduces FNDC5/irisin secretion
in WAT. Accordingly, the CABA animals that were subjected to
severe fasting showed a decrease of FNDC5/irisin secretion,
especially in VAT. Although the effect of fasting on direct
FNDC5/irisin secretion by muscle tissue remains unknown, the
circulating FNDC5/irisin levels observed in our experiment
suggest that fasting induces muscle secretion of this protein. Thus,
we analyzed possible WAT browning by assaying the BAT-specific
uncoupling protein 1 (Ucp1) responsible for nonshivering
thermogenesis to maintain body temperature [37]. Unexpectedly,
we detected Ucp1 expression in VAT among anorexic animals
and their control counterparts with the same exercise training
(EXER) or food restriction (CABA). The Ucp1 expression in these
cases parallels the FNDC5/irisin circulating levels. Moreover, we
observed that Ucp1 expression in VAT disappears after 3 weeks of
exercise. In this regard, Boström and collaborators described a
great amount of browning in subcutaneous fat and, to a minor
extent, also in visceral fat after 3 weeks of wheel running [1]. We
believe that our findings concerning VAT are not comparable
with those described by Boström because these authors used white
adipose tissue from the epididymis as visceral tissue. In our
experiments, we chose the WAT located inside the peritoneal
cavity around the internal organs, which we believe better
resembles the human visceral fat close to the liver. Moreover,
we previously demonstrated that rat gonadal fat from the
epididymis shows a different pattern of protein secretion compared
with the visceral fat in the peritoneal cavity [14]. Nevertheless, we
were unable to detect Ucp1 expression after three weeks of
exercise in our experimental model.
Figure 6. Mature adipocytes in rats and human adipose tissue secrete FNDC5. The occurrence of FNDC5 in rat and human adipocytes as
well as SVCs secretomes (A); in differentiated and non-differentiated 3T3-L1 cell secretomes (B); and in human subcutaneous and visceral adipose
tissues and secretomes (C).
doi:10.1371/journal.pone.0060563.g006
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The liver-forced expression of FNDC5 and the consequent
increase of FNDC5/irisin circulating levels significantly improved
glucose tolerance and reduced fasting insulin in obese and insulin-
resistant mice according to Boström and colleagues [1]. In our
study, however, we detected an over-secretion of FNDC5/irisin in
the WAT of obese animals. Although Boström et al. did not report
the grade of FNDC5/irisin secretion by muscle in obese compared
to lean animals; we detected a significant elevation of circulating
FNDC5/irisin in DIO animals. Our result suggests that animals
with exposure to high levels of FNDC5/irisin might develop a
resistance to this protein. If this hypothesis is true, the
unquestionable role of muscle stimulating several of the beneficial
effects of exercise would need to be explained by alternative
mechanisms.
Globally, FNDC5/irisin showed a secretion pattern similar to
other well-known adipokines (e.g., leptin); thus, our results also
suggest a feedback pattern in which adipose tissue might be
sensitive to FNDC5/irisin circulating levels. Because adipose tissue
is determined to preserve its energy saving function to maintain
energy balance, it stands to reason to find that elevated levels of
circulating FNDC5/irisin correspond to decreased levels of irisin
secretion by adipose tissue of the studied animals. Under this
situation, irisin resistance might explain the high secretion pattern
of WAT observed in the DIO animals; however, further research
should be performed to confirm this hypothesis. In view of the fact
that Zucker obese rats with no functional leptin receptor seem not
to be affected by circulating FNDC5/irisin levels, other mecha-
nisms related to leptin might be also implicated.
Recently, Huh and collaborators published a report about the
role of circulating irisin and FNCD5 in humans [38]. Contrary to
our results, they found very low mRNA expression of FNDC5 in
human fat compared with muscle using a TissueScan qPCR
Array. Generally, mRNA expression is assumed to be predictive of
protein expression level; importantly, however, the correlation
between mRNA and protein expression has been described as
moderately or weakly positive (correlation coefficients ranging
from 0.2 to 0.6), especially with regard to secreted proteins
[39,40]. Our results illustrate this fact well; thus, the correlation
between FNDC5/irisin mRNA levels and secretion levels was not
always evident. Several independent considerations should be
taken into account with regard to the data published by Huh and
collaborators concerning the nature and origin of their samples
which makes comparisons with our data difficult.
On the other hand, a recent study performed by Stengel and
collaborators strongly supports our results [41]. These authors
observed higher circulating irisin levels in obese patients compared
with normal weight and anorexic patients, which resulted in a
correlation between irisin and body weight and fat mass among
other variables. These data suggest that circulating irisin is affected
under conditions of altered BMI, with the highest levels in obese
patients. Taking these premises, and based in our direct explants
secretion studies, we postulate that the muscle/adipose irisin
secretion ratio might vary by the physiological situation. Thus,
with exercise training, muscle tissue would strongly affect the
FNDC5 circulating levels, whereas in atypical BMI cases such as
obesity, adipose tissue would actively elevate FNDC5/irisin.
Our data sets the basis for additional research since many
questions remain to be answered concerning FNDC5/irisin such
as the nature of the FNDC5/irisin receptor (which is yet to be
discovered) and the precise role of the soluble long and short forms
of FNDC5/irisin. In conclusion, this study reveals that rat skeletal
muscle sheds the long form of FNDC5 whose secretion depends on
the muscle fiber type. More interestingly, this work is the first to
identify FNDC5/irisin as a potential adipokine secreted by WAT
and especially by subcutaneous adipose tissue. Given that exercise,
nutritional status and pathological conditions such as obesity
influence WAT-secreted FNDC5/irisin, our findings suggest a
regulatory mechanism influenced by circulating FNDC5/irisin in
a feedback process.
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